Shanghai Juncell Therapeutics
Clinical trials sponsored by Shanghai Juncell Therapeutics, explained in plain language.
-
Immune cell attack: new hope for advanced melanoma patients
Disease control CompletedThis study tested a new treatment called GC101 TIL for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells, grown in a lab, to fight the cancer. The goal was to check safety and see if tumors shrink. 18 patient…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 17, 2026 10:39 UTC
-
Supercharged immune cells show promise in Hard-to-Treat gynecologic cancers
Disease control CompletedThis study tested a new treatment for people with advanced gynecologic tumors that had stopped responding to standard therapies. Doctors took immune cells from each patient's tumor, modified them in the lab to make them stronger, and then infused them back into the patient. The g…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Immune cells from tumors show promise in advanced cancer trial
Disease control CompletedThis early-stage trial tested a therapy made from a patient's own immune cells (tumor-infiltrating lymphocytes) to fight advanced solid tumors like melanoma, cervical cancer, and lung cancer. 43 adults participated to find the safest dose and check for side effects. The goal was …
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC